FINRA Opens a Sweep Into “Worst-of” Structured Notes: What It Means for Investors

If a broker recommended a non-principal protected “worst-of” structured note and a large part of that money is now gone, a development from May 2026 is worth a few minutes of your time. FINRA has opened a review of how brokerage firms supervised the sale of these notes. FINRA aimed the review at the practice that does the most damage in these accounts: too much of one customer’s savings sitting in a single high-risk note. The regulator laid this out in a sweep letter published in May 2026.

What FINRA Is Reviewing

A sweep letter is a targeted information request. FINRA sends it to a set of brokerage firms and asks them to produce records about one specific practice. According to FINRA’s May 2026 sweep letter, the regulator “is conducting a review of firm practices related to supervision of concentrations in non-principal protected ‘worst-of’ structured notes, a higher risk structured product.” FINRA says it is examining “how firms ensure compliance with Regulation Best Interest (Reg BI),” including “Reg BI’s care and conflict of interest obligations,” and with FINRA rules “when they permit their registered representatives to recommend those products to their customers.”

The records FINRA wants cover sales from January 1, 2022, through December 31, 2025. The letter asks each firm for its “written supervisory procedures (WSPs) related to structured notes and complex products.” It wants an explanation of how the firm sorted these products by risk, and a description of any limits the firm placed on recommendations, “including but not limited to concentration limitations.” It also asks firms to describe the supervisory alerts they ran for structured notes, naming “any concentration alerts or Reg BI/suitability alerts” as examples. FINRA asks, too, whether firms trained their representatives before letting them sell these products, and what the firms told customers about the notes and the compensation earned on them.

Two of the eight requests are about money. FINRA tells each firm to “state how registered representatives were compensated for sales of structured notes,” and to describe how the firm “identifies and mitigates product-related conflicts of interest associated with recommendations of structured notes.” Put those two requests side by side and you can see what FINRA is after. The regulator wants to know whether brokers had a financial reason to sell a note, and whether anyone at the firm was watching for it. That pairing is where we start building a claim: if the note paid the broker more than a suitable alternative would have, the recommendation needs a hard look.

What a “Worst-of” Structured Note Is

A structured note is a debt security whose payoff is tied to the performance of one or more reference assets, usually stock indexes or individual stocks. A “worst-of” note ties the payoff to the single weakest name in a basket. FINRA’s letter defines the term in a footnote: worst-of structured notes are “principal-at-risk structured notes that may result in a reduction or cessation in interest payments, and/or a reduced return of principal at maturity, based on the worst-performing asset in a group of two or more reference assets.”

Read that definition slowly, because it explains the trap. The investor doesn’t need a market crash. They don’t even need most of the basket to fall. One weak name out of three or four can switch off the interest and shrink the principal paid back at maturity. “Non-principal protected” means there’s no floor under any of it.

These notes get sold on a headline yield. Next to a CD or an investment-grade bond, the rate looks generous. That yield isn’t a gift. It’s the price the buyer is paid for taking on a risk that’s easy to soft-pedal at the kitchen table and hard for a retail customer to model on their own. When we look at structured products in our practice, the headline rate is almost always the thing the client remembers, and the downside mechanics are the thing nobody walked them through.

Why This Matters for Investors

When a broker recommends a structured note to a retail customer, that recommendation is governed by Regulation Best Interest. The rule requires the broker to “act in the best interest of the retail customer at the time the recommendation is made,” and it bars the broker from placing “the financial or other interest of the broker, dealer, or natural person who is an associated person of a broker or dealer making the recommendation ahead of the interest of the retail customer.” The brokerage firm has its own duty under FINRA Rule 3110 to supervise that recommendation. A failure to supervise the sale of a high-risk note is a claim against the firm, separate from anything the individual broker did.

Concentration is where worst-of notes turn dangerous. One such note, sized as a small slice of a diversified portfolio, may be defensible. A broker who routes a large share of a customer’s retirement savings into that same note, or into several of them at once, turns a product that was risky by design into a threat to the customer’s principal. Overconcentration is the recurring fact pattern in the structured-note losses we see. A worst-of note will fall when its weakest underlying does. The broker’s choice to make that note a large share of the portfolio is what turns a market loss into a loss the client can’t absorb.

A sweep is not an enforcement case, and that distinction matters. FINRA is gathering records to understand an industry-wide practice. It hasn’t found that any firm broke a rule, and it hasn’t named anyone. The sweep doesn’t return a dollar to any investor. If a worst-of note has already cost you money, that recovery is a separate track, and it doesn’t wait on FINRA. It runs through a claim against the brokerage firm that recommended the note and was supposed to supervise the sale. Whether the conduct gets framed as an unsuitable recommendation, investment fraud, or a supervisory breakdown, the forum is usually FINRA arbitration.

Steps to Take Right Now

1. Gather your account statements, trade confirmations, and any correspondence with your broker or firm, including emails, texts, and written materials about the investments.
2. Look up your broker on FINRA BrokerCheck at brokercheck.finra.org to review their full disclosure record.
3. Contact a securities arbitration attorney for a consultation to evaluate your options.

Talk to Rosenberger + Kawabata

Rosenberger + Kawabata represents retail investors in FINRA arbitration proceedings involving structured products and other unsuitable recommendations. If a broker put a large part of your portfolio into worst-of structured notes and you’ve taken losses, contact Rosenberger + Kawabata online for a free and confidential consultation, or call (310) 894-6921.

This post discusses a FINRA regulatory review. A sweep letter is an information request, not a disciplinary proceeding or a finding of wrongdoing against any brokerage firm.